Staufen1 controls mitochondrial metabolism via HIF2α in embryonal rhabdomyosarcoma and promotes tumorigenesis
- 17 October 2023
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 80 (11) , 1-28
Abstract
Elevated mitochondrial metabolism promotes tumorigenesis of Embryonal Rhabdomyosarcomas (ERMS). Accordingly, targeting oxidative phosphorylation (OXPHOS) could represent a therapeutic strategy for ERMS. We previously demonstrated that genetic reduction of Staufen1 (STAU1) levels results in the inhibition of ERMS tumorigenicity. Here, we examined STAU1-mediated mechanisms in ERMS and focused on its potential involvement in regulating OXPHOS. We report the novel and differential role of STAU1 in mitochondrial metabolism in cancerous versus non-malignant skeletal muscle cells (NMSkMCs). Specifically, our data show that STAU1 depletion reduces OXPHOS and inhibits proliferation of ERMS cells. Our findings further reveal the binding of STAU1 to several OXPHOS mRNAs which affects their stability. Indeed, STAU1 depletion reduced the stability of OXPHOS mRNAs, causing inhibition of mitochondrial metabolism. In parallel, STAU1 depletion impacted negatively the HIF2α pathway which further modulates mitochondrial metabolism. Exogenous expression of HIF2α in STAU1-depleted cells reversed the mitochondrial inhibition and induced cell proliferation. However, opposite effects were observed in NMSkMCs. Altogether, these findings revealed the impact of STAU1 in the regulation of mitochondrial OXPHOS in cancer cells as well as its differential role in NMSkMCs. Overall, our results highlight the therapeutic potential of targeting STAU1 as a novel approach for inhibiting mitochondrial metabolism in ERMS.Keywords
Funding Information
- Canadian Cancer Research Society (24303)
This publication has 65 references indexed in Scilit:
- LRPPRC/SLIRP suppresses PNPase-mediated mRNA decay and promotes polyadenylation in human mitochondriaNucleic Acids Research, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Childhood RhabdomyosarcomaJournal of Dental Research, 2011
- HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responsesProceedings of the National Academy of Sciences, 2009
- SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAsGenes & Development, 2008
- Rhabdomyosarcoma cells show an energy producing anabolic metabolic phenotype compared with primary myocytesMolecular Cancer, 2008
- HIF‐1α and HIF‐2α have divergent roles in colon cancerInternational Journal of Cancer, 2008
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative GroupsJournal of Clinical Oncology, 2008
- Biology of hypoxia-inducible factor-2α in development and diseaseCell Death & Differentiation, 2008
- A genome-wide approach identifies distinct but overlapping subsets of cellular mRNAs associated with Staufen1- and Staufen2-containing ribonucleoprotein complexesRNA, 2007